Articles from DataMEDS AI, Inc.
Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient engagement tools
By DataMEDS AI, Inc. · Via ACCESS Newswire · August 5, 2026
Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store
By DataMEDS AI, Inc. · Via ACCESS Newswire · July 31, 2026
Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX Platform
By DataMEDS AI, Inc. · Via ACCESS Newswire · July 29, 2026
TAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey, today announced an updated record date for the distribution of the Dream Bowl 2026 Meme Coin (https://www.biconomy.com/exchange/DREAM1_USDT) to DataMEDS stockholders. On December 3, 2025, DataMEDS announced that it would distribute one (1) Dream Bowl 2026 Meme Coin for every one (1) share of DataMEDS Health common stock held as of a designated record date. On July 20, 2026, DataMEDS previously set a new record date of July 31, 2026 for determining stockholders entitled to receive the Dream Bowl 2026 Meme Coin. Today, the Company further updated the record date to August 7, 2026.
By DataMEDS AI, Inc. · Via ACCESS Newswire · July 27, 2026
Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX)
By DataMEDS AI, Inc. · Via ACCESS Newswire · July 22, 2026